ArticleBiomedicines2021

A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment.

Chiao-Chieh Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.